BTZ
Showing 1 - 25 of 37
Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,
Not yet recruiting
- Tuberculosis, Pulmonary
- Other Specified Pulmonary Tuberculosis
- BTZ-043
- +3 more
-
Cape Town, South Africa
- +3 more
Jun 22, 2023
Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug
Completed
- Pulmonary Tuberculoses
- Other Specified Pulmonary Tuberculosis
- BTZ-043
- +3 more
-
Cape Town, South Africa
- +1 more
Aug 9, 2022
Tuberculosis, Tuberculosis, Pulmonary, Bacterial Infections Respiratory Trial in Groningen (500mg BTZ-043 containing 3.7 MBq of
Completed
- Tuberculosis
- +4 more
- 500mg BTZ-043 containing 3.7 MBq of [14C]BTZ-043
-
Groningen, NetherlandsPRA Health Sciences (PRA) - Early Development Services (EDS)
Oct 19, 2021
Relapsed or Refractory Multiple Myeloma Trial (Daratumumab, Pomalidomide)
Withdrawn
- Relapsed or Refractory Multiple Myeloma
- (no location specified)
Jan 26, 2023
Bortezomib Treatment on Mantle Cell Lymphoma in Chinese
Completed
- Lymphoma, Mantle-Cell
-
Beijing, China
- +8 more
Nov 5, 2020
Multiple Myeloma Trial in Worldwide (panobinostat capsules, bortezomib injection, dexamethasone tablets)
Active, not recruiting
- Multiple Myeloma
- panobinostat capsules
- +2 more
-
Fayetteville, Arkansas
- +79 more
Mar 15, 2021
Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)
Recruiting
- Multiple Myeloma
- BB2121
- +2 more
-
Birmingham, Alabama
- +33 more
Jan 26, 2023
Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- bb2121
- +8 more
-
Birmingham, Alabama
- +59 more
Dec 13, 2022
ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Recruiting
- Colon Cancer Stage II
- Colon Cancer Stage III
-
Roma, RM, ItalyAOU Sant'Andrea
Oct 24, 2023
Chronic Inflammation, Inflammaging Trial in Greenbrae, Suwanee (Dietary supplement, Placebo)
Recruiting
- Chronic Inflammation
- Inflammaging
- Dietary supplement
- Placebo
-
Greenbrae, California
- +1 more
Jun 7, 2022
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in New Brunswick, Bronx,
Completed
- DS Stage I Plasma Cell Myeloma
- +3 more
- Busulfan
- +4 more
-
New Brunswick, New Jersey
- +3 more
Aug 11, 2020
Efficacy, and Optimal Dose Finding Study for Multiple Myeloma
Recruiting
- Multiple Myeloma
-
Bucheon, Korea, Republic of
- +23 more
Dec 8, 2020
Infections, Bacterial Trial in Anaheim, Austin (Gepotidacin RC Tablet, Gepotidacin HSWG Tablet, Gepotidacin Capsule)
Completed
- Infections, Bacterial
- Gepotidacin RC Tablet
- +2 more
-
Anaheim, California
- +1 more
Sep 14, 2020